Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0

K-Number: K173468 · 2018-02-23

Decision Date2018-02-23
Product CodeJAK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0 is a medical device manufactured by Toshibamedical Systems Corporation. It received FDA 510(k) clearance on 2018-02-23 under approval number K173468. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0?

Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0 is a medical device that received FDA 510(k) clearance on 2018-02-23. It is manufactured by Toshibamedical Systems Corporation. The 510(k) number is K173468.

When was Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0 approved by the FDA?

Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0 received FDA 510(k) clearance on 2018-02-23, under approval number K173468.

What company makes Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0?

Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0 is manufactured by Toshibamedical Systems Corporation.

What is the FDA product code for Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0?

The FDA product code for Aquilion Precision (TSX-304A/2) V8.6 with FIRST 3.0 is JAK.

Related Clinical Trials

Related PubMed Literature

Other Devices by Toshibamedical Systems Corporation

View all 27 devices →

Related Devices (Code: JAK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.